<p><b>(A)</b> ARPE-19 cells were treated with 200 or 400μM H<sub>2</sub>O<sub>2</sub> and then chymotrypsin-like proteasome activity was measured at 24h post-exposure using a fluorogenic substrate. Control (Ctrl) = No H<sub>2</sub>O<sub>2</sub> <b>(B)</b> Chymotrypsin-like proteasome activity was detected in RPE cells treated with the proteasome specific inhibitor lactacystin (4nM and 25μM, 12h). Ctrl = DMSO control <b>(C)</b> qRT-PCR was used to measure the p62 mRNA level following lactacystin treatment (25μM, 12h). Ctrl = DMSO control <b>(D)</b> p62 protein level was examined by western blot after proteasome specific inhibitor lactacystin (25μM, 12h) exposure. Ctrl = DMSO control. Data represent the mean + S.E.M. for three samples per gro...
<p><b>A–C:</b> HDAC3 inhibitors inhibit proteasome activity. Three different HDAC3 inhibitors were a...
<p>(a) Products of quantitative PCR for p22phox mRNA in untreated MV4-11 cells (Unt) and cells treat...
<p>(A) The immunoreactivity of CHOP in cells expressing hVAPB<sup>WT</sup> and hVAPB<sup>P56S</sup> ...
<p><b>(A)</b> ARPE-19 cells were pre-treated with, and subsequently challenged with, H<sub>2</sub>O<...
<p>The same cells from Figure 2 were cultured in KH without (<b>A</b>) or with (<b>B</b>) amino acid...
<p><b>(A)</b> ARPE-19 cells were exposed to 400μM H<sub>2</sub>O<sub>2</sub> and autophagy was monit...
<p>The slices were treated daily with vehicle for 4 days (0-day control group) or with 5 μM lactacys...
<p><b>A:</b> Immunoblotting analysis of degradation of P56S-VAPB in the presence or absence of prote...
<p>Murine RAW 264.7 (2×10<sup>5</sup> cells/ml) cells were treated with 50 mM or 100 mM ethanol (EtO...
<p>(A) Proteasome inhibitors MG132 and EPOX reduced the numbers of LANA-positive cells. HUVEC grown ...
<p>PC12 cells were exposed to 1 μmol/L lactacystin at different times and TH-phospho Ser19 or TH-pho...
<p><b>A</b>) Tubular cells pre-treated with 10 µM parthenolide, 10 µM lactacystin or 20 µM MG132 wer...
<p>(<b>A</b>) Quantitative analysis of GFP fluorescence of cells expressing αsyn-GFP<sub>11</sub>+ G...
<p>PC12 cells were treated with 1 μmol/L lactacystin (A), a specific proteasome inhibitor, or 5 nmol...
<p>(A) HEK293T cells were treated with each 20 µM MG132 or 10 µM lactacystin for the indicated times...
<p><b>A–C:</b> HDAC3 inhibitors inhibit proteasome activity. Three different HDAC3 inhibitors were a...
<p>(a) Products of quantitative PCR for p22phox mRNA in untreated MV4-11 cells (Unt) and cells treat...
<p>(A) The immunoreactivity of CHOP in cells expressing hVAPB<sup>WT</sup> and hVAPB<sup>P56S</sup> ...
<p><b>(A)</b> ARPE-19 cells were pre-treated with, and subsequently challenged with, H<sub>2</sub>O<...
<p>The same cells from Figure 2 were cultured in KH without (<b>A</b>) or with (<b>B</b>) amino acid...
<p><b>(A)</b> ARPE-19 cells were exposed to 400μM H<sub>2</sub>O<sub>2</sub> and autophagy was monit...
<p>The slices were treated daily with vehicle for 4 days (0-day control group) or with 5 μM lactacys...
<p><b>A:</b> Immunoblotting analysis of degradation of P56S-VAPB in the presence or absence of prote...
<p>Murine RAW 264.7 (2×10<sup>5</sup> cells/ml) cells were treated with 50 mM or 100 mM ethanol (EtO...
<p>(A) Proteasome inhibitors MG132 and EPOX reduced the numbers of LANA-positive cells. HUVEC grown ...
<p>PC12 cells were exposed to 1 μmol/L lactacystin at different times and TH-phospho Ser19 or TH-pho...
<p><b>A</b>) Tubular cells pre-treated with 10 µM parthenolide, 10 µM lactacystin or 20 µM MG132 wer...
<p>(<b>A</b>) Quantitative analysis of GFP fluorescence of cells expressing αsyn-GFP<sub>11</sub>+ G...
<p>PC12 cells were treated with 1 μmol/L lactacystin (A), a specific proteasome inhibitor, or 5 nmol...
<p>(A) HEK293T cells were treated with each 20 µM MG132 or 10 µM lactacystin for the indicated times...
<p><b>A–C:</b> HDAC3 inhibitors inhibit proteasome activity. Three different HDAC3 inhibitors were a...
<p>(a) Products of quantitative PCR for p22phox mRNA in untreated MV4-11 cells (Unt) and cells treat...
<p>(A) The immunoreactivity of CHOP in cells expressing hVAPB<sup>WT</sup> and hVAPB<sup>P56S</sup> ...